Jeremy Warner, MD, MS, FAMIA, FASCO
@hemoncwarner.bsky.social
Professor of Medicine and Biostatistics at Brown University, Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS), CTO of HemOnc.org, co-founder of the COVID-19 and Cancer Consortium (CCC19), EIC of JCO CCI. Views my own.
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
At @brown.edu, instead of majors we have concentrations. It might also be surprising that @brownbiostatistics.bsky.social is home to the university's #statistics concentration.
Program director Professor Alice Paul, explains the advantages of studying statistics in a school of public health. ⬇️
Program director Professor Alice Paul, explains the advantages of studying statistics in a school of public health. ⬇️
Inside Brown's new statistics curriculum
By eliminating redundant coursework, expanding elective opportunities and introducing R programming earlier in the program, the Department of Biostatistics is pivoting toward a deeper, student-focused and computational approach to the field.
sph.brown.edu
March 25, 2026 at 7:09 PM
At @brown.edu, instead of majors we have concentrations. It might also be surprising that @brownbiostatistics.bsky.social is home to the university's #statistics concentration.
Program director Professor Alice Paul, explains the advantages of studying statistics in a school of public health. ⬇️
Program director Professor Alice Paul, explains the advantages of studying statistics in a school of public health. ⬇️
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
This storm has officially topped the Blizzard of ‘78. For everyone’s safety, and to help our emergency management teams perform their duties, please stay home.
February 23, 2026 at 6:55 PM
This storm has officially topped the Blizzard of ‘78. For everyone’s safety, and to help our emergency management teams perform their duties, please stay home.
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
Gavin Newsom just announced that California will be the first state to join the World Health Organization.
This is in direct defiance of Donald Trump, who just pulled the United States out of the organization.
This is in direct defiance of Donald Trump, who just pulled the United States out of the organization.
January 23, 2026 at 7:44 PM
Gavin Newsom just announced that California will be the first state to join the World Health Organization.
This is in direct defiance of Donald Trump, who just pulled the United States out of the organization.
This is in direct defiance of Donald Trump, who just pulled the United States out of the organization.
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
Color me shocked.
Doctors Catch Cancer-Diagnosing AI Extracting Patients' Race Data and Being Racist With It
A new study reveals an alarming bias present in four leading AI cancer screening tools, related to race, gender, and age.
futurism.com
December 20, 2025 at 3:20 PM
Color me shocked.
I'm honored to publish this article with great colleagues: Informatics Perspectives on the National Cancer Policy Forum Workshop “Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond” | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/... #JCOCCI
Informatics Perspectives on the National Cancer Policy Forum Workshop “Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond” | JCO Clinical Cancer Informat...
The National Cancer Policy Forum workshop Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries
and Beyond examined the current state of cancer registries and how they...
ascopubs.org
November 20, 2025 at 1:53 PM
I'm honored to publish this article with great colleagues: Informatics Perspectives on the National Cancer Policy Forum Workshop “Enabling 21st Century Applications for Cancer Surveillance Through Enhanced Registries and Beyond” | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/... #JCOCCI
Reimagining Evidence: Artificial Intelligence Synthetic Data Generation for Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Reimagining Evidence: Artificial Intelligence Synthetic Data Generation for Cancer Research | JCO Clinical Cancer Informatics
ascopubs.org
November 19, 2025 at 5:55 PM
Reimagining Evidence: Artificial Intelligence Synthetic Data Generation for Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics
ascopubs.org
November 5, 2025 at 11:03 PM
Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Kids or Adults: Reflections on Choosing a Path in Oncology | ASCO Connection connection.asco.org/do/kids-adul...
Kids or Adults: Reflections on Choosing a Path in Oncology
Dr. Elaine Fan shares considerations and personal reflections on choosing to purse the pediatric or adult oncology track to help guide trainees that are torn between the two.
connection.asco.org
October 16, 2025 at 9:39 PM
Kids or Adults: Reflections on Choosing a Path in Oncology | ASCO Connection connection.asco.org/do/kids-adul...
Exciting new article: Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @ascocancer.bsky.social
Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics
Advancements in oncology are accelerating in the fields of artificial intelligence
(AI) and machine learning. The complexity and multidisciplinary nature of oncology
necessitate a cautious approach to...
ascopubs.org
September 24, 2025 at 4:18 PM
Exciting new article: Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @ascocancer.bsky.social
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social
September 24, 2025 at 12:51 AM
JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social
America in 2025 or Hollow Knight: Silksong? www.mcsweeneys.net/articles/ame...
America in 2025 or Hollow Knight: Silksong?
1. It’s the hotly anticipated sequel of a late 2010s, grimdark existential nightmare.
2. The economy is really, really bad. Like. Really bad.
3. Th...
www.mcsweeneys.net
September 24, 2025 at 12:20 PM
America in 2025 or Hollow Knight: Silksong? www.mcsweeneys.net/articles/ame...
Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatic...
PURPOSETo evaluate a generative artificial intelligence (GAI) framework for creating readable
lay abstracts and summaries (LASs) of urologic oncology research, while maintaining
accuracy, completeness...
ascopubs.org
September 19, 2025 at 12:17 PM
Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI #mCODE
ASCO Publications
ascopubs.org
September 3, 2025 at 9:39 PM
Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI #mCODE
Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
ASCO Publications
ascopubs.org
September 3, 2025 at 9:38 PM
Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics
The integration of artificial intelligence (AI) into health care promises transformative
advancements in diagnostics, treatment, and operational efficiency. However, this
transformation introduces sig...
ascopubs.org
August 27, 2025 at 5:26 PM
Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Inf...
PURPOSEChemotherapy is the primary treatment for metastatic nonseminomatous germ cell tumors
(mNSGCTs), but patients often encounter postchemotherapy residual disease. Accurate
noninvasive methods are...
ascopubs.org
August 27, 2025 at 5:25 PM
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics
PURPOSESocial Determinants of Health (SDoH) have a significant effect on health outcomes
and inequalities. SDoH can be extracted from electronic health records (EHR) to aid
policy development and rese...
ascopubs.org
July 30, 2025 at 7:54 PM
Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics
PURPOSEThe development of colorectal liver metastases (CRLMs) is associated with poor prognosis,
and recent data suggest that metastasis to the liver is associated with resistance
to immunotherapy. We...
ascopubs.org
July 25, 2025 at 1:20 PM
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics
PURPOSEThe present study aimed to investigate the role of body composition as an independent
image-derived biomarker for clinical outcome prediction in a clinical trial cohort
of patients with relapse...
ascopubs.org
July 25, 2025 at 1:20 PM
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics
PURPOSEConsumer wearable devices provide new opportunities for measuring patterns of objective
daily physical activity throughout cancer treatment. In addition to capturing step
counts, these devices ...
ascopubs.org
July 16, 2025 at 6:09 PM
Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics
PURPOSEPrevious studies have consistently reported disparities in electronic health record
portal enrollment. Among patients enrolled in a portal, it is less clear whether there
are disparities in usa...
ascopubs.org
July 16, 2025 at 6:08 PM
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @daniellebitterman.bsky.social
Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names | JCO Clinical Cancer Informatics
PURPOSETo evaluate the performance and consistency of large language models (LLMs) across
brand and generic oncology drug names in various clinical tasks, addressing concerns
about potential fluctuati...
ascopubs.org
June 18, 2025 at 5:15 PM
Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @daniellebitterman.bsky.social
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
I heard this morning that my informatics colleague Dr. Atul Butte passed after a battle with cancer. He was a giant in the field & inspired many of us over his distinguished career. He was a passionate champion of the power of big data & his impact on our field is immeasurable. RIP Atul & thanks.
June 14, 2025 at 1:20 PM
I heard this morning that my informatics colleague Dr. Atul Butte passed after a battle with cancer. He was a giant in the field & inspired many of us over his distinguished career. He was a passionate champion of the power of big data & his impact on our field is immeasurable. RIP Atul & thanks.
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
May 31, 2025 at 4:05 PM
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...